Skip to content

To compare blood parameters in type 2 diabetes mellitus patients with and without nerve disorders .

Comparative study of neutrophil-to-lymphocyte ratio in type 2 diabetes mellitus patients with peripheral neuropathy versus type 2 diabetes mellitus patients without peripheral neuropathy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057374
Enrollment
150
Registered
2023-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications

Interventions

Control Intervention1: Nil: Nil

Sponsors

Kashish chaudhary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of type 2 diabetes mellitus of any gender with and without peripheral neuropathy

Exclusion criteria

Exclusion criteria: TYPE 1 DIABETES MELLITUS DIABETIC KETOACIDOSIS , HYPEROSMOLAR NON-KETOTC COMA CORONARY ARTERY DISEASE , HEART FAILURE ACTIVE INFECTION OR INFECTION IN LAST ONE MONTH CANCER ACCUTE POISONING BLOOD DISORDERS THAT AFFECT NEUTROPHILS AND LYMPHOCYTES(eg MYELOPROLIFERATIVE DISORDERS AND LEUKEMIA) SMOKING , SIGNIFICANT ALCOHOL INTAKE(MORE THAN 30g PER DAY IN MALES AND MORE THAN 20g PER DAY IN FEMALES) MEDICATIONS THAT AFFECT NLR (STEROIDS AND IMMUNOSUPPRESSIVE DRUGS) HYPOTHYROIDISM CHRONIC KIDNEY DISEASE VITAMIN B12 DEFICIENCY PEOPLE LIVING WITH HIV-AIDS(PLHA) HISTORY OF AUTOIMMUNE DISORDERS HISTORY OF BLOOD TRANSFUSION DURING PAST 2 WEEKS PREGNANCY

Design outcomes

Primary

MeasureTime frame
To determine neutrophil to lymphocyte ratio in type 2 diabetes mellitus patients with and without peripheral neuropathyTimepoint: Baseline

Secondary

MeasureTime frame
To compare the NLR in type 2 diabetes mellitus patients with & without peripheral neuropathyTimepoint: Baseline

Countries

India

Contacts

Public ContactSumit pal singh chawla

Guru gobind singh medical college and hospital

drsumitpsc@gmail.com8146444220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026